TEVA
Teva Pharmaceutical Industries
$37.34
+1.44%
2026-08-21
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Key Fundamentals
P/E Ratio
61.28
Forward P/E
11.96
EPS (TTM)
$0.60
ROE
9.7%
Revenue Growth (YoY)
-0.8%
Profit Margin
4.1%
Debt/Equity
217.79
Price/Book
5.53
Beta
0.88
Market Cap
$42.85B
Avg Volume (10D)
5.4M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$37.83
60D Low
$29.60
Avg Volume
5.3M
Latest Close
$37.34
Get breakout alerts for TEVA
Sign up for Breakout Scanner to receive daily notifications when TEVA triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Teva Pharmaceutical Industries (TEVA) is listed on the New York Stock Exchange (NYSE). Breakout Scanner monitors TEVA daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TEVA operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.